RxDoctor Payments Data

Kevin Dolehide, DO

Gastroenterology · Naples, FLNPI 1255434122

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 33.4% of the total. Reporting peaked in 2019 at $10,654 and has fallen 88.0% since, to $1,277 in 2025. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,994in general payments, 2019–2025

Across 203 payments — averaging $78.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
  • AbbVie$4K
  • Redhill Biopharma Inc.$2K
  • Romark Laboratories, LC$1K
  • Olympus Medical Systems Corporation$850
  • Boston Scientific$580
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$1,85012%
  • Speaking & faculty fees$7,40046%
  • Travel & lodging$1,2748%
  • Food & beverage$5,46434%
  • Education$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,994 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024
$100,285
Medicare patients
387
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium25$238

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Naples

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →